iShares Global Healthcare ETF (NYSEARCA:IXJ) Reaches New 1-Year High – Still a Buy?

Posted by Anthony Miller on Feb 27th, 2026

Shares of iShares Global Healthcare ETF (NYSEARCA:IXJ – Get Free Report) reached a new 52-week high on Friday . The company traded as high as $101.78 and last traded at $101.71, with a volume of 129458 shares trading hands. The stock had previously closed at $100.31.

iShares Global Healthcare ETF Price Performance

The business has a 50 day moving average of $99.30 and a 200 day moving average of $94.22. The firm has a market capitalization of $4.76 billion, a price-to-earnings ratio of 21.58 and a beta of 0.64.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of IXJ. LOM Asset Management Ltd bought a new stake in iShares Global Healthcare ETF in the third quarter valued at approximately $26,000. Nvest Wealth Strategies Inc. acquired a new position in shares of iShares Global Healthcare ETF in the 4th quarter valued at $30,000. Hantz Financial Services Inc. bought a new stake in shares of iShares Global Healthcare ETF in the 2nd quarter valued at $31,000. Franklin Resources Inc. raised its stake in iShares Global Healthcare ETF by 80.0% during the 2nd quarter. Franklin Resources Inc. now owns 360 shares of the company’s stock worth $31,000 after buying an additional 160 shares during the period. Finally, Arax Advisory Partners acquired a new stake in iShares Global Healthcare ETF during the 4th quarter worth $31,000.

iShares Global Healthcare ETF Company Profile

(Get Free Report)

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.